Seeking Alpha

More on Flexion Q2 results

  • Flexion Therapeutics (FLXN +1.6%) Q2 results: Revenues: $0; Net Loss: ($5.9M) (-29.0%); Loss Per Share: ($0.38) (+93.5%); Quick Assets: $72.0M (+339.0%).
  • No financial guidance given.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector